Meeder Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Meeder Asset Management's ANGO Position: Q4 2022 in Review
Meeder Asset Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 255 shares — an estimated $5K sold.
Meeder Asset Management first reported a position in ANGO in Q2 2017 and held it in 20 quarters. The position peaked at $349K in Q3 2019. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.
- Meeder Asset Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
- Meeder Asset Management sold 255 AngioDynamics shares in Q4 2022, an estimated $5K.
- Meeder Asset Management first reported a position in AngioDynamics in Q2 2017 and held it in 20 quarters.
- Meeder Asset Management's AngioDynamics position peaked at $349K in Q3 2019.
- 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.
Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.